Clinical Trial: Proteogenomics for Follicular Cell-derived Thyroid Cancer: Development of a Classification and Prognosis Prediction Model

U.S., May 15 -- ClinicalTrials.gov registry received information related to the study (NCT06969768) titled 'Proteogenomics for Follicular Cell-derived Thyroid Cancer: Development of a Classification and Prognosis Prediction Model' on April 30.

Brief Summary: This study aims to refine the molecular classification of thyroid cancer (TC) using a multi-omics approach. By identifying a novel gene set and applying decision-tree modeling, the study seeks to improve diagnostic accuracy and predict tumor progression in BRAFV600E-like and RAS-like TC subtypes. Protein biomarkers were validated via immunohistochemistry (IHC), with findings confirmed across external datasets.

Study Start Date: Feb. 21, 2018

Study Type: OBSERVATIONAL

Condition: Thy...